Medicine Supply Notification: Carbamazepine 100mg/5ml oral suspension sugar free (Accord)
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Carbamazepine 100mg/5ml oral suspension sugar free (Accord)
MSN/2024/077
Tier 2 – medium impact
Date of issue: 18th July 2024
- Carbamazepine 100mg/5ml oral suspension sugar free from Accord is out of stock until mid-August 2024.
- Tegretol® (carbamazepine) 100mg/5ml liquid remains available but is unable to support an increase in demand. Please note, Novartis have issued communications regarding the sorbitol content of Tegretol® 100mg/5ml liquid and a change to the maximum daily dose
- Carbamazepine (Tegretol®) 100mg, 200mg and 400mg immediate release tablets remain available and can support an increase in demand
- Only carbamazepine 100mg and 200mg immediate release tablets from Medreich remain available and can support an increase in demand.
- Carbamazepine 100mg and 200mg tablets from Crescent are out of stock until mid-August 2024 and therefore cannot support increased demand. Please see the Medicines Supply Tool for further information (MSN/2024/040).
- Unlicensed supplies of carbamazepine 100mg/5ml oral suspension can be sourced from Specials manufacturers and specialist importers; lead times vary.
Unlicensed products
The following Specials manufacturers have confirmed they can manufacture carbamazepine 100mg/5ml oral suspension (please note there may be other companies that can also manufacture supplies):
- Eaststone (product is sugar-free; contains carbohydrates)
- IPS (product is sugar-free; contains carbohydrates)
- Nova Laboratories (product contains sugar)
- Target (product is sugar-free; contains carbohydrates)
The following specialist importers have confirmed they can source unlicensed Tegretol (carbamazepine) 100mg/5ml oral suspension (please note there may be other companies that can also source supplies).
Specialist importers can provide further information as to whether the product contains sugar and carbohydrates:
If there is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems an EPS prescription for the unlicensed product cannot be issued. Where a prescriber wishes to prescribe a specially manufactured or imported product, an FP10 paper prescription should be issued as ‘carbamazepine 100mg/5ml oral suspension (Special Order)’ and endorsed by the pharmacy as a non-Part VIIIB special with the following information:
- Amount dispensed over pack size used;
- Invoice price per pack size from which the order was supplied less any discount or rebate;
- Manufacturers’/importers’ MHRA licence number;
- Batch number of the product supplied;
- SP
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
